M&A
Microsoft faces EC fine for failure to comply with browser undertaking
18 Jul 2012
Regulators have threatened to penalise Microsoft for its failure to offer 28 million European customers the ability to choose their web browser
Human Genome Sciences agrees to GSK's revised $3-bn offer
17 Jul 2012
US biopharmaceutical company Human Genome Sciences yesterday agreed to be acquired by GlaxoSmithKline Plc (GSK) for a sweetened $3 billion
Thermo Fisher to acquire One Lambda for $925 mn
16 Jul 2012
GSK to close Human Genome Sciences acquisition with $2.8-bn revised offer: report
16 Jul 2012
GlaxoSmithKline is close to acquiring Human Genome Sciences for about $2.8 billion, two months after it went hostile with its $2.59-billion bid for the US biopharmaceutical firm
Tinkler's consortium launches $5.3-bn bid for Australia's Whitehaven Coal
14 Jul 2012
Tinkler, Whitehaven’s largest shareholder with a 21.4 per cent stake, is offering to pay $5.20 a share, a premium of 50 per cent to the miner's yesterday closing price
Bain Capital, Singapore’s GIC plan joint bid for Genpact stake: report
13 Jul 2012
The two are reported to be in talks to jointly bid for a 41 per cent stake in the IT outsourcing company, for $1.5 billion to $2 billion
Australia’s Telstra sells NZ subsidiary to Vodafone for A$660 million
13 Jul 2012
The sale is expected to boost Telstra’s war chest of free cash flow to up to $3 billion in the next three years
Australia’s Telstra sells NZ subsidiary to Vodafone for A$660 million
13 Jul 2012
The sale is expected to boost Telstra’s war chest of free cash flow to up to $3 billion in the next three years
Australia’s Telstra sells NZ subsidiary to Vodafone for A$660 million
13 Jul 2012
The sale is expected to boost Telstra’s war chest of free cash flow to up to $3 billion in the next three years